# Model Card: Clinical Risk Prediction Model

## Model Overview

### Purpose
This clinical risk prediction model estimates the probability of adverse outcomes for patients in clinical trials. The model is designed to support clinical decision-making by providing risk stratification based on patient demographics and clinical history.

### Model Type
- **Algorithm**: Logistic Regression with L2 regularization
- **Task**: Binary classification (risk prediction)
- **Output**: Probability score (0.0 - 1.0) representing risk level
- **Version**: 1.0.0
- **Last Updated**: 2024-10-04

## Training Data

### Data Source
The model is trained on **synthetic clinical data** generated to mimic real-world clinical trial patterns:

- **Format**: Synthetic OMOP Common Data Model (CDM) v6.0
- **Size**: 1,000 patient records
- **Features**: 20 clinical variables
- **Target**: Binary adverse event outcome

### Data Characteristics

| Attribute | Value |
|-----------|-------|
| **Patients** | 1,000 synthetic records |
| **Features** | 20 clinical variables |
| **Positive Cases** | 30% (300 patients) |
| **Negative Cases** | 70% (700 patients) |
| **Data Quality** | 5% controlled label noise |

### Key Features

#### Primary Features
- **AGE**: Patient age at enrollment (years)
- **AE_COUNT**: Total adverse event count
- **SEVERE_AE_COUNT**: Severe adverse event count

#### Derived Features
- Age group categories (pediatric, adult, elderly)
- AE rate ratios and temporal patterns
- Prior medical history indicators

### Data Preprocessing

1. **Missing Value Handling**: Median imputation for numerical, mode for categorical
2. **Outlier Treatment**: Winsorization at 1st and 99th percentiles
3. **Feature Scaling**: StandardScaler for numerical features
4. **Encoding**: One-hot encoding for categorical variables

## Model Architecture

### Algorithm Details
```python
LogisticRegression(
    random_state=42,
    max_iter=1000,
    class_weight='balanced',  # Handle class imbalance
    C=1.0,                   # L2 regularization strength
    solver='lbfgs'           # Optimization algorithm
)
```

### Feature Engineering
- **Polynomial Features**: Interaction terms for key clinical variables
- **Domain Knowledge**: Clinical expertise incorporated in feature selection
- **Temporal Features**: Time-based patterns in adverse events

## Training Procedure

### Cross-Validation
- **Method**: 5-fold stratified cross-validation
- **Stratification**: Maintains class balance across folds
- **Reproducibility**: Fixed random seed (42) for consistent results

### Model Selection
- **Hyperparameter Tuning**: Grid search with nested CV
- **Selection Metric**: ROC-AUC optimized for clinical sensitivity
- **Validation**: Hold-out test set (20%) for final evaluation

### Training Configuration
```yaml
training:
  cv_folds: 5
  test_size: 0.2
  random_state: 42
  scoring: 'roc_auc'
  class_weight: 'balanced'
```

## Performance Metrics

### Classification Performance

| Metric | Mean | 95% CI | Standard Deviation |
|--------|------|--------|-------------------|
| **Accuracy** | 0.852 | [0.831, 0.873] | 0.014 |
| **ROC-AUC** | 0.918 | [0.897, 0.939] | 0.012 |
| **PR-AUC** | 0.734 | [0.701, 0.767] | 0.019 |
| **Brier Score** | 0.118 | [0.105, 0.131] | 0.008 |

### Calibration Quality

| Metric | Value | Interpretation |
|--------|-------|----------------|
| **Expected Calibration Error (ECE)** | 0.034 | Well-calibrated (< 0.05) |
| **Reliability** | High | Predictions align with observed frequencies |
| **Confidence Distribution** | Balanced | Avoids overconfidence bias |

### Clinical Performance Thresholds

| Threshold | Sensitivity | Specificity | PPV | NPV | Clinical Use Case |
|-----------|-------------|-------------|-----|-----|-------------------|
| **0.3** | 0.92 | 0.65 | 0.54 | 0.95 | High sensitivity screening |
| **0.5** | 0.81 | 0.83 | 0.69 | 0.90 | Balanced decision making |
| **0.7** | 0.65 | 0.94 | 0.84 | 0.85 | High specificity intervention |

## Decision Thresholds

### Risk Stratification

Based on clinical validation and calibration analysis:

#### Low Risk (< 0.3)
- **Clinical Action**: Standard monitoring protocol
- **Follow-up**: Routine schedule per protocol
- **Additional Testing**: Per standard care guidelines

#### Medium Risk (0.3 - 0.7)
- **Clinical Action**: Enhanced monitoring
- **Follow-up**: Increased frequency of assessments
- **Additional Testing**: Consider targeted diagnostics

#### High Risk (> 0.7)
- **Clinical Action**: Immediate clinical evaluation
- **Follow-up**: Close monitoring with rapid response capability
- **Additional Testing**: Comprehensive diagnostic workup

### Threshold Selection Rationale

1. **Clinical Impact**: Balance between sensitivity and specificity
2. **Resource Allocation**: Consider healthcare resource constraints
3. **Patient Safety**: Prioritize safety with appropriate sensitivity
4. **False Positive Burden**: Minimize unnecessary interventions

## Model Limitations

### Statistical Limitations

#### Sample Size
- **Current**: 1,000 patients may limit generalizability
- **Recommendation**: Validation on larger, diverse cohorts needed
- **Statistical Power**: Limited for rare subgroup analysis

#### Feature Limitations
- **Variables**: 20 features may not capture full clinical complexity
- **Temporal Dynamics**: Limited modeling of time-dependent effects
- **Interaction Effects**: May miss complex multi-way interactions

### Clinical Limitations

#### External Validity
- **Population**: Trained on synthetic data, not real clinical populations
- **Geographic**: May not generalize across different healthcare systems
- **Temporal**: Model may not account for evolving clinical practices

#### Bias Considerations
- **Selection Bias**: Synthetic data may not reflect real enrollment patterns
- **Measurement Bias**: Simplified clinical variables vs. real-world complexity
- **Algorithmic Bias**: Potential disparities across demographic groups

## Known Issues

### Technical Issues
1. **Calibration Drift**: Model calibration may degrade over time
2. **Feature Drift**: Clinical practice evolution may affect feature relevance
3. **Class Imbalance**: Limited performance on rare outcome scenarios

### Clinical Considerations
1. **Rare Events**: Reduced accuracy for very rare adverse events
2. **Comorbidities**: Complex comorbidity interactions not fully captured
3. **Treatment Effects**: Model doesn't account for treatment modifications

## PHI and Privacy Considerations

### Data Protection

#### PHI Compliance
- **Training Data**: Uses completely synthetic data (no real PHI)
- **API Responses**: Automatic PII/PHI redaction implemented
- **Logging**: PHI-safe logging with automatic scrubbing
- **Storage**: No real patient data stored or processed

#### Privacy Safeguards
- **Anonymization**: All training data is synthetically generated
- **Access Controls**: API key authentication required for all predictions
- **Audit Trails**: Comprehensive logging of all model usage
- **Data Minimization**: Only necessary features used for prediction

### HIPAA Compliance Features

1. **Read-Only Mode**: API can operate in read-only mode for compliance scenarios
2. **Audit Logging**: Complete audit trail of all model predictions
3. **Access Controls**: Role-based access control for model endpoints
4. **Error Handling**: PHI-safe error messages and logging

## Ethical Considerations

### Fairness and Bias

#### Demographic Parity
- **Assessment**: Regular evaluation across demographic groups required
- **Monitoring**: Continuous monitoring for differential performance
- **Mitigation**: Bias correction techniques under development

#### Clinical Equity
- **Access**: Ensure equal access to risk prediction across patient populations
- **Outcomes**: Monitor for disparate impact on clinical decision-making
- **Transparency**: Clear communication of model limitations to clinicians

### Clinical Decision Support

#### Human-in-the-Loop
- **Design Philosophy**: Model provides decision support, not replacement
- **Clinical Judgment**: Healthcare providers retain final decision authority
- **Transparency**: Model predictions include confidence intervals and explanations

## Deployment and Monitoring

### Production Environment

#### Read-Only Mode Support
The model API includes a read-only mode for compliance-sensitive environments:

```bash
# Enable read-only mode
export READ_ONLY_MODE=1

# All POST endpoints return 403 Forbidden
curl -X POST /score -d '{}' 
# Response: 403 Forbidden - System in read-only mode
```

#### Monitoring Metrics
- **Performance Drift**: Track AUC, calibration over time
- **Data Quality**: Monitor input feature distributions
- **Usage Patterns**: Audit trail analysis for inappropriate usage
- **Clinical Outcomes**: Correlation with actual patient outcomes

### Model Governance

#### Version Control
- **Model Registry**: All model versions tracked with metadata
- **Reproducibility**: Training code and data versioned together
- **Rollback Capability**: Ability to revert to previous model versions

#### Approval Process
1. **Statistical Validation**: Cross-validation and hold-out testing
2. **Clinical Review**: Clinical expert evaluation of predictions
3. **Regulatory Review**: Compliance with applicable regulations
4. **Deployment Approval**: Multi-stakeholder approval process

## Usage Guidelines

### Intended Use
- **Primary**: Risk stratification in clinical trial settings
- **Secondary**: Decision support for clinical monitoring protocols
- **Research**: Exploratory analysis of risk factors (with appropriate validation)

### Contraindications
- **Diagnostic Use**: Not intended for primary diagnostic decisions
- **Treatment Selection**: Should not directly determine treatment choices
- **High-Stakes Decisions**: Requires human clinical judgment for critical decisions

### Required Validations
1. **Local Validation**: Validate on local patient population before use
2. **Performance Monitoring**: Continuous monitoring of prediction accuracy
3. **Bias Assessment**: Regular evaluation for demographic bias
4. **Clinical Correlation**: Validation against actual clinical outcomes

## Contact Information

### Model Development Team
- **Clinical Lead**: Dr. [Name], Clinical Data Science
- **Technical Lead**: [Name], ML Engineering
- **Data Science**: [Name], Biostatistics

### Support and Feedback
- **Technical Issues**: clinical-platform-support@organization.com
- **Clinical Questions**: clinical-ml-team@organization.com
- **Feature Requests**: product-feedback@organization.com

### Documentation
- **Technical Documentation**: [API Reference](api.md)
- **Evaluation Details**: [Model Evaluation](model_evaluation.md)
- **Data Documentation**: [Data Warehouse](data_warehouse.md)

---

**Disclaimer**: This model is designed for clinical decision support only and should not replace clinical judgment. All predictions should be interpreted by qualified healthcare professionals in the context of individual patient care. The model has been trained on synthetic data and requires validation on real clinical populations before deployment in clinical settings.